References
- 1Volkmann J, Wolters A, Kupsch A, Müller J, Kühn AA, Schneider GH, et al. Pallidal deep brain stimulation in patients with primary generalized or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012; 11(12): 1029–1038. DOI: 10.1016/S1474-4422(12)70257-0
- 2Krause P, Völzmann S, Ewert S, Kupsch A, Schneider GH, Kühn AA. Long-term effects of bilateral pallidal deep brain stimulation in dystonia: a follow-up between 8 and 16 years. J Neurol. 2020; 267(6): 1622–1631. DOI: 10.1007/s00415-020-09745-z
- 3Tsuboi T, Cauraugh JH, Wong JK, Okun MS, Ramirez-Zamora A. Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis. J Neurol Neurosurg Psychiatry. 2020; 91(9): 938–944. DOI: 10.1136/jnnp-2019-322575
- 4Andrews C, Aviles-Olmos I, Mariz M, Foltynie T. Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. J Neurol Neurosurg Psychiatry. 2010; 81(12): 1383–1389. DOI: 10.1136/jnnp.2010.207993
- 5Tierney TS, Lozano AM. Surgical treatment for secondary dystonia. Mov Disord. 2012; 27(13): 1598–605. DOI: 10.1002/mds.25204
- 6Tsuboi T, Cif L, Coubes P, Ostrem JL, Romero DA, Miyagi Y, et al. Secondary worsening following DYT1 dystonia deep brain stimulation: A multi-country cohort. Front Hum Neurosci. 2020; 14: 242. DOI: 10.3389/fnhum.2020.00242
- 7Artusi CA, Dwivedi A, Romagnolo A, Bortolani S, Marsili L, Imbalzano G, et al. Differential response to pallidal deep brain stimulation among monogenic dystonias: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2020; 91(4): 426–433. DOI: 10.1136/jnnp-2019-322169
- 8De Vloo P, Lee DJ, Dallapiazza RF, Rohani M, Fasano A, Munhoz RP, et al. Deep brain stimulation for pantothenate kinase-associated neurodegeneration: A meta-analysis. Mov Disord. 2019; 34(2): 264–273. DOI: 10.1002/mds.27563
- 9Timmermann L, Pauls KAM, Wieland K, Jech R, Kurlemann G, Sharma N, et al. Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain. 2010; 133: 701–712. DOI: 10.1093/brain/awq022
- 10Hayflick SJ, Kurian MA, Hogarth P. Neurodegeneration with brain iron accumulation. Handb Clin Neurol. 2018; 147: 293–305. DOI: 10.1016/B978-0-444-63233-3.00019-1
- 11Gregory A, Hayflick SJ.
Pantothenate kinase-associated neurodegeneration . In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews®. Seattle: University of Washington, Seattle; 1993.https://www.ncbi.nlm.nih.gov/books/NBK1490/ . Accessed January 6, 2024. - 12Hogarth P, Kurian MA, Gregory A, Csányi B, Zagustin T, Kmiec T, et al. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration. Mol Genet Metab. 2017; 120(3): 278–287. DOI: 10.1016/j.ymgme.2016.11.004
- 13Limotai N, Go C, Oyama G, Hwynn N, Zesiewicz T, Foote K, et al. Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms. J Neurol. 2011; 258(11): 2069–2074. DOI: 10.1007/s00415-011-6075-0
- 14Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider G, Poewe W, et al. Pallidal deep-brain stimulation in primary or segmental dystonia. N Engl J Med. 2006; 355(19): 1978–1990. DOI: 10.1056/NEJMoa063618
- 15Isaias IU, Alterman RL, Tagliati M. Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration. Brain. 2008; 131: 1895–1902. DOI: 10.1093/brain/awn120
- 16Pauls KAM, Krauss JK, Kämpfer CE, Kühn AA, Schrader C, Südmeyer M, et al. Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia. Parkinsonism Relat Disord. 2017; 43: 38–48. DOI: 10.1016/j.parkreldis.2017.06.023
- 17Isaias IU, Volkmann J, Kupsch A, Burgunder J, Ostrem JL, Alterman RL, et al. Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration. J Neurol. 2011; 258(8): 1469–1476. DOI: 10.1007/s00415-011-5961-9
- 18Vasques X, Cif L, Gonzalez V, Nicholson C, Coubes P. Factors predicting improvement in primary generalized dystonia treated by pallidal deep brain stimulation. Mov Disord. 2009; 24(6): 846–853. DOI: 10.1002/mds.22433
- 19Krause M, Fogel W, Tronnier V, Pohle S, Hörtnagel K, Thyen U, et al. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to panthothenate kinase-associated neurodegeneration. Mov Disord. 2006; 21(12): 2255–2257. DOI: 10.1002/mds.21166
- 20Adamovicová M, Jech R, Urgošík D, Spacková N, Krepelová A. Pallidal stimulation in siblings with pantothenate kinase-associated neurodegeneration: four-year follow-up. Mov Disord. 2011; 26(1): 184–187. DOI: 10.1002/mds.23349
- 21Picillo M, Pellecchia MT, Vitale C, Barone P, Amboni M. Pallidal deep brain stimulation in atypical pantothenate-kinase associated neurodegeneration: six-year follow-up. Mov Disord. 2014; 29(2): 276–277. DOI: 10.1002/mds.25709
- 22Woo KA, Kim H, Jeon S, Park HR, Park KW, Lee SH, et al. Long-term outcomes of deep brain stimulation in pantothenate kinase-associated neurodegeneration-related dystonia. J Mov Disord. 2022; 15(3): 241–248. DOI: 10.14802/jmd.22002
- 23Pauls KAM, Timmerman L. Deep brain stimulation in pantothenate kinase associated neurodegeneration: challenges for the future. Eur J Neurol. 2012; 19(4): 533–534. DOI: 10.1111/j.1468-1331.2011.03585.x
- 24Houeto J, Yelnik J, Bardinet E, Vercueil L, Krystkowiak P, Mesnage V, et al. Acute deep-brain stimulation of the internal and external globus pallidus in primary dystonia: functional mapping of the pallidum. Arch Neurol. 2007; 64(9): 1281–1286. DOI: 10.1001/archneur.64.9.1281
- 25Tisch S, Zrinzo L, Limousin P, Bhatia KP, Quinn N, Ashkan K, et al. Effect of electrode contact location on clinical efficacy of pallidal deep brain stimulation in primary generalized dystonia. J Neurol Neurosurg Psychiatry. 2007; 78(12): 1314–1319. DOI: 10.1136/jnnp.2006.109694
- 26Mikati MA, Yehya A, Darwish H, Karam P, Comair Y. Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol. 2009; 13(1): 61–64. DOI: 10.1016/j.ejpn.2008.01.006
- 27Ostrem JL, Luciano MS, Dodenhoff KA, Ziman N, Markun LC, Racine CA, et al. Subthalamic nucleus deep brain stimulation in isolated dystonia: A 3-year follow-up study. Neurology. 2017; 88(1): 25–35. DOI: 10.1212/WNL.0000000000003451
- 28Lin S, Shu Y, Zhang C, Wang L, Huang P, Pan Y, et al. Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia: A 3-year follow-up. Eur J Neurol. 2023; 30(9): 2629–2640. DOI: 10.1111/ene.15895
- 29Liu Z, Liu Y, Yang Y, Wang L, Dou W, Guo J, et al. Subthalamic nuclei stimulation in patients with pantothenate kinase-associated neurodegeneration (PKAN). Neuromodulation. 2017; 20(5): 484–491. DOI: 10.1111/ner.12549
- 30Li H, Li D, Yang W, Yan H, Zhao Z, Yang H. Deep brain stimulation (DBS) with subthalamic nucleus (STN) as target for pediatric patients with PKAN. World Neurosurg. 2022; 161: e317–e322. DOI: 10.1016/j.wneu.2022.03.130